Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 377

1.

CASP8 SNP D302H (rs1045485) Is Associated with Worse Survival in MYCN-Amplified Neuroblastoma Patients.

Rihani A, De Wilde B, Zeka F, Laureys G, Francotte N, Tonini GP, Coco S, Versteeg R, Noguera R, Schulte JH, Eggert A, Stallings RL, Speleman F, Vandesompele J, Van Maerken T.

PLoS One. 2014 Dec 11;9(12):e114696. doi: 10.1371/journal.pone.0114696. eCollection 2014.

PMID:
25502557
[PubMed - in process]
Free PMC Article
2.

A multi-level examination of how the organizational context relates to readiness to implement prevention and evidence-based programming in community settings.

Chilenski SM, Olson JR, Schulte JA, Perkins DF, Spoth R.

Eval Program Plann. 2014 Oct 22;48C:63-74. doi: 10.1016/j.evalprogplan.2014.10.004. [Epub ahead of print]

PMID:
25463014
[PubMed - as supplied by publisher]
3.

First Report on an Inotropic Peptide Activating TTX-Sensitive, "Neuronal" Sodium Currents in the Heart.

Kirchhof P, Tal T, Fabritz L, Klimas J, Nesher N, Schulte JS, Ehling P, Kanyshkova T, Budde T, Nikol S, Fortmueller L, Stallmeyer B, Müller FU, Schulze-Bahr E, Schmitz W, Zlotkin E, Kirchhefer U.

Circ Heart Fail. 2014 Nov 25. pii: CIRCHEARTFAILURE.113.001066. [Epub ahead of print]

PMID:
25424392
[PubMed - as supplied by publisher]
4.

Clinical decisions: Screening an asymptomatic person for genetic risk--polling results.

Schulte J, Rothaus CS, Adler JN, Phimister EG.

N Engl J Med. 2014 Nov 13;371(20):e30. doi: 10.1056/NEJMclde1411151. No abstract available.

PMID:
25390759
[PubMed - indexed for MEDLINE]
Free Article
5.

Approach to approximating the pair distribution function of inhomogeneous hard-sphere fluids.

Lurie-Gregg P, Schulte JB, Roundy D.

Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Oct;90(4):042130. Epub 2014 Oct 21.

PMID:
25375461
[PubMed - in process]
6.

Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells.

Pajtler KW, Mahlow E, Odersky A, Lindner S, Stephan H, Bendix I, Eggert A, Schramm A, Schulte JH.

Oncotarget. 2014 Nov 30;5(22):11180-92.

PMID:
25361003
[PubMed - in process]
Free Article
7.

ALK pERKs up MYCN in neuroblastoma.

Lindner S, Henssen A, Astrahantseff K, Schulte JH.

Sci Signal. 2014 Oct 28;7(349):pe27. doi: 10.1126/scisignal.2005940.

PMID:
25351246
[PubMed - in process]
8.

MiR-34a deficiency accelerates medulloblastoma formation in vivo.

Thor T, Künkele A, Pajtler KW, Wefers AK, Stephan H, Mestdagh P, Heukamp L, Hartmann W, Vandesompele J, Sadowski N, Becker L, Garrett L, Hölter SM, Horsch M, Calzada-Wack J, Klein-Rodewald T, Racz I, Zimmer A, Beckers J, Neff F, Klopstock T, Antonellis PD, Zollo M, Wurst W, Fuchs H, Gailus-Durner V, Schüller U, de Angelis MH, Eggert A, Schramm A, Schulte JH.

Int J Cancer. 2014 Oct 27. doi: 10.1002/ijc.29294. [Epub ahead of print]

PMID:
25348795
[PubMed - as supplied by publisher]
9.

Cardiac Function Is Regulated by B56α-mediated Targeting of Protein Phosphatase 2A (PP2A) to Contractile Relevant Substrates.

Kirchhefer U, Brekle C, Eskandar J, Isensee G, Kučerová D, Müller FU, Pinet F, Schulte JS, Seidl MD, Boknik P.

J Biol Chem. 2014 Dec 5;289(49):33862-73. doi: 10.1074/jbc.M114.598938. Epub 2014 Oct 15.

PMID:
25320082
[PubMed - in process]
10.

Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsampling.

Lee S, Rahnenführer J, Lang M, De Preter K, Mestdagh P, Koster J, Versteeg R, Stallings RL, Varesio L, Asgharzadeh S, Schulte JH, Fielitz K, Schwermer M, Morik K, Schramm A.

PLoS One. 2014 Oct 8;9(10):e108818. doi: 10.1371/journal.pone.0108818. eCollection 2014.

PMID:
25295525
[PubMed - in process]
Free PMC Article
11.

MYCN-targeting miRNAs are predominantly downregulated during MYCN‑driven neuroblastoma tumor formation.

Beckers A, Van Peer G, Carter DR, Mets E, Althoff K, Cheung BB, Schulte JH, Mestdagh P, Vandesompele J, Marshall GM, De Preter K, Speleman F.

Oncotarget. 2014 Sep 16. [Epub ahead of print]

PMID:
25294817
[PubMed - as supplied by publisher]
Free Article
12.

MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis.

Bleeker G, van Eck-Smit BL, Zwinderman KH, Versteeg R, van Noesel MM, Kam BL, Kaspers GJ, van Schie A, Kreissman SG, Yanik G, Hero B, Schmidt M, Laureys G, Lambert B, Ora I, Schulte JH, Caron HN, Tytgat GA.

Eur J Nucl Med Mol Imaging. 2014 Sep 30. [Epub ahead of print]

PMID:
25267348
[PubMed - as supplied by publisher]
13.

A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies.

Althoff K, Beckers A, Bell E, Nortmeyer M, Thor T, Sprüssel A, Lindner S, De Preter K, Florin A, Heukamp LC, Klein-Hitpass L, Astrahantseff K, Kumps C, Speleman F, Eggert A, Westermann F, Schramm A, Schulte JH.

Oncogene. 2014 Sep 1. doi: 10.1038/onc.2014.269. [Epub ahead of print]

PMID:
25174395
[PubMed - as supplied by publisher]
14.

p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.

Dreidax D, Bannert S, Henrich KO, Schröder C, Bender S, Oakes CC, Lindner S, Schulte JH, Duffy D, Schwarzl T, Saadati M, Ehemann V, Benner A, Pfister S, Fischer M, Westermann F.

Hum Mol Genet. 2014 Dec 20;23(25):6826-37. doi: 10.1093/hmg/ddu406. Epub 2014 Aug 7.

PMID:
25104850
[PubMed - in process]
15.

Clinical decisions. Starting statins--polling results.

Schulte JM, Rothaus CS, Adler JN.

N Engl J Med. 2014 Jul 24;371(4):e6. doi: 10.1056/NEJMclde1407177. No abstract available.

PMID:
25054734
[PubMed - indexed for MEDLINE]
Free Article
16.

miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin.

Althoff K, Lindner S, Odersky A, Mestdagh P, Beckers A, Karczewski S, Molenaar JJ, Bohrer A, Knauer S, Speleman F, Epple M, Kozlova D, Yoon S, Baek K, Vandesompele J, Eggert A, Schramm A, Schulte JH.

Int J Cancer. 2014 Jul 21. doi: 10.1002/ijc.29091. [Epub ahead of print]

PMID:
25046253
[PubMed - as supplied by publisher]
17.

HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women).

Schulte JM, Bellamy AR, Hook EW 3rd, Bernstein DI, Levin MJ, Leone PA, Sokol-Anderson ML, Ewell MG, Wolff PA, Heineman TC, Belshe RB.

South Med J. 2014 Feb;107(2):79-84. doi: 10.1097/SMJ.0000000000000062.

PMID:
24926671
[PubMed - indexed for MEDLINE]
18.

Secrets of solid state and aqueous solution structures of [Ni(tmdta)](2-).

Meier R, Platas-Iglesias C, Heinemann FW, Linti G, Schulte J, Srivastava SK.

Inorg Chem. 2014 Jul 7;53(13):6684-97. doi: 10.1021/ic5004325. Epub 2014 Jun 11.

PMID:
24918934
[PubMed - in process]
19.

Early targets of miR-34a in neuroblastoma.

De Antonellis P, Carotenuto M, Vandenbussche J, De Vita G, Ferrucci V, Medaglia C, Boffa I, Galiero A, Di Somma S, Magliulo D, Aiese N, Alonzi A, Spano D, Liguori L, Chiarolla C, Verrico A, Schulte JH, Mestdagh P, Vandesompele J, Gevaert K, Zollo M.

Mol Cell Proteomics. 2014 Aug;13(8):2114-31. doi: 10.1074/mcp.M113.035808. Epub 2014 Jun 9.

PMID:
24912852
[PubMed - in process]
20.

Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.

Abbasi A, Corpeleijn E, Gansevoort RT, Gans RO, Struck J, Schulte J, Hillege HL, van der Harst P, Stolk RP, Navis G, Bakker SJ.

Diabetologia. 2014 Sep;57(9):1842-9. doi: 10.1007/s00125-014-3278-9. Epub 2014 Jun 4.

PMID:
24893865
[PubMed - in process]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk